Vyne Therapeutics Inc (VYNE)

Jun 15, 2026

VYNE (VYNE) merger with Yarrow: $100M financing, 35.8441 exchange ratio - Stock Titan

Jun 15, 2026

Jun 15, 2026

Zhang Xiaofan discloses 1.87M shares (5.6%) in VYNE Therapeutics (VYNE) - Stock Titan

Jun 15, 2026

Jun 08, 2026

VYNE Therapeutics (VYNE) Edges Higher in Quiet Trading, Testing Key Resistance at $0.69New Listing Stocks - newsline.com

Jun 08, 2026

Jun 06, 2026

VYNE Therapeutics (VYNE) Consolidates Near Support After Slight PullbackMACD Signal Stocks - newsline.com

Jun 06, 2026

Jun 02, 2026

[Form 4] VYNE Therapeutics Inc. Insider Trading Activity - Stock Titan

Jun 02, 2026

Jun 01, 2026

VYNE Therapeutics (VYNE) Posts Modest Gain, Holds Above Key SupportHedge Fund Favorites - newsline.com

Jun 01, 2026

May 29, 2026

VYNE Therapeutics (VYNE) Edges Lower as Shares Test Key Support Near $0.65Standard Deviation - thelegaladvocate.com

May 29, 2026

May 21, 2026

VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline - TipRanks

May 21, 2026

May 21, 2026

VYNE to Advance YB-101 into Phase 2 in Q2 2026; $200M Raised, Phase 2a Readout Expected H2 2027 - TradingView

May 21, 2026

May 21, 2026

Yarrow reverse merger refocuses VYNE (NASDAQ: VYNE) with $200M war chest - Stock Titan

May 21, 2026

May 18, 2026

VYNE Therapeutics (VYNE) price target decreased by 38.46% to 2.04 - MSN

May 18, 2026

May 17, 2026

VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 17, 2026

May 15, 2026

Nantahala (NASDAQ: VYNE) reports 2,000,000-share stake representing 6.00% - Stock Titan

May 15, 2026

May 15, 2026

Yarrow merger to refocus VYNE (NASDAQ: VYNE) with $200M financing - Stock Titan

May 15, 2026

May 15, 2026

MSN Money - MSN

May 15, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 04, 2026

Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

The regulatory exposure in VYNE Therapeutics (VYNE) results | Q4 2025: Earnings Beat EstimatesNon-GAAP Earnings - The Legal Advocate

May 03, 2026

Apr 28, 2026

VYNE Therapeutics (NASDAQ: VYNE) to become Yarrow Bioscience after merger - Stock Titan

Apr 28, 2026

Apr 23, 2026

VYNE Therapeutics Inc. (VYNE) beats Q4 2025 EPS expectations significantly, yet shares edge slightly lower in today's trading.Special Dividend - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 22, 2026

VYNE Therapeutics Inc. (VYNE) reports narrower Q4 2025 loss than estimates, yet shares dip slightly in today’s trading.Post Announcement - Xã Vĩnh Công

Apr 22, 2026

Apr 21, 2026

VYNE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026

Apr 20, 2026

VYNE Therapeutics (VYNE) Stock: Market Structure Shift (+3.21%) 2026-04-20Swing Entry Points - newser.com

Apr 20, 2026

Apr 18, 2026

Is VYNE Therapeutics (VYNE) stock suitable for new investors (Technical Weakness) 2026-04-18Sell Signals - UBND thành phố Hải Phòng

Apr 18, 2026

Apr 13, 2026

Death Cross: Is VYNE Therapeutics Inc a play on infrastructure spending2026 Movers & Weekly Momentum Stock Picks - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Market Pulse: Can VYNE Therapeutics Inc expand its profit margins2026 Retail & Weekly High Return Forecasts - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Breakout Watch: Can VYNE Therapeutics Inc deliver consistent dividends2026 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Layoff Watch: Can VYNE Therapeutics Inc sustain earnings growthMarket Performance Report & Momentum Based Trading Signals - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

How does VYNE Therapeutics (VYNE) Stock react to Fed policy | Price at $0.61, Down 0.57%Crowd Breakout Signals - Newser

Apr 10, 2026

Apr 08, 2026

Weekly Earnings: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Aug PostEarnings: What analysts say about VYNE Therapeutics Inc stockEarnings Overview Report & Real-Time Market Trend Scan - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Is VYNE Therapeutics (VYNE) Stock exposed to global risks | Price at $0.61, Up 2.53%Sentiment Shift - newsline.com

Apr 08, 2026

Apr 07, 2026

Published on: 2026-04-08 14:06:22 - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Rate Cut: What are analysts price targets for VYNE Therapeutics Inc2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn

Apr 06, 2026

Apr 03, 2026

VYNE Stock Analysis: VYNE Therapeutics Inc. $0.6 Biotech Minor Dip Stock Review - The Legal Advocate

Apr 03, 2026

Apr 02, 2026

VYNE (VYNE) CFO has 4,007 shares withheld to cover RSU taxes - Stock Titan

Apr 02, 2026

Apr 02, 2026

VYNE Therapeutics (VYNE) CSO covers taxes with 2,876 shares - Stock Titan

Apr 02, 2026

Apr 02, 2026

VYNE (VYNE) legal chief has 4,007 shares withheld to cover RSU taxes - Stock Titan

Apr 02, 2026

Apr 02, 2026

VYNE (NASDAQ: VYNE) CEO stock withheld to cover RSU tax bill - Stock Titan

Apr 02, 2026